Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorC. R. Bard

About this trial

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surgery.

Eligibility criteria

Qualifiers

Must be ≥ 18 years of age

Elective, open midline laparotomy ≥ 5 cm

Willing and able to provide written informed consent

Hernia risk equal to moderate or greater

Disqualifiers

Previous hernia repair

Emergent surgery

Creation of skin flaps is preplanned

Preplanned 2nd surgery

Trial design

Treatments tested in this trial

  • Phasix™ Mesh

Treatment groups

477 Participants
are divided into 2 treatment groups

Sponsors and collaborators